Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive ability of postnatal total bilirubin rate of rise endures.

Pediatric research·2026
Same author

Citrate-functionalized manganese oxide nanoparticles in neonates ≥35 weeks gestation at risk of acute bilirubin encephalopathy: a phase 1 observational trial.

Pediatric research·2026
Same author

Evidence That Cerebral Visual Impairment May Evolve after Initial Brain Injury.

Ophthalmology·2026
Same author

Need for accurate and actionable neonatal bilirubin test results.

Pediatric research·2025
Same author

Inhibitory Potency of a Plant-Based Zinc Protoporphyrin on Heme Oxygenase Activity.

Neonatology·2025
Same author

Neonatal home phototherapy: need for standardized curriculum.

Pediatric research·2025

Related Experiment Video

Updated: Jun 1, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
05:13

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

The need to implement effective phototherapy in resource-constrained settings.

Vinod K Bhutani1, Benjamin K Cline, Krista M Donaldson

  • 1Division of Neonatal-Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Lucile Packard Children's Hospital, Stanford, CA 94304, USA. bhutani@stanford.edu

Seminars in Perinatology
|June 7, 2011
PubMed
Summary

Phototherapy effectively treats neonatal hyperbilirubinemia using specific light wavelengths and irradiance. This study proposes minimum device criteria for safe and practical phototherapy, especially in resource-limited settings.

More Related Videos

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

Related Experiment Videos

Last Updated: Jun 1, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
05:13

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

Area of Science:

  • Neonatal Medicine
  • Biomedical Engineering
  • Public Health

Background:

  • Phototherapy is the standard treatment for neonatal unconjugated hyperbilirubinemia.
  • Effective phototherapy requires specific light parameters (wavelength, irradiance) and coverage.
  • Current guidelines are challenging to implement in resource-constrained clinical settings.

Purpose of the Study:

  • To define minimum device performance criteria for safe and practical phototherapy.
  • To address implementation barriers for phototherapy in low-resource environments.
  • To ensure effective prophylactic use of phototherapy to prevent severe hyperbilirubinemia.

Main Methods:

  • Literature review of evidence-based phototherapy guidelines.
  • Analysis of technical requirements for effective phototherapy delivery.
  • Development of proposed minimum criteria for phototherapy devices.

Main Results:

  • Optimal phototherapy involves specific blue light wavelengths (450 ± 20 nm) and irradiance (≥30 μW/cm²/nm).
  • Ideal treatment covers up to 80% of infant body surface area.
  • Minimum device criteria are proposed to bridge implementation gaps.

Conclusions:

  • Establishing minimum device standards can facilitate safe and effective phototherapy globally.
  • This approach supports the prophylactic use of phototherapy in diverse clinical settings.
  • Addressing technical feasibility is crucial for managing neonatal hyperbilirubinemia worldwide.